Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Note
  • Published:

Hyperglycemia and hepatic tumors in ICR mice neonatally injected with streptozotocin

Lab Animal volume 43, pages 242–249 (2014)Cite this article

Abstract

Repeated, low-dose administration of streptozotocin (STZ) is widely used to induce insulin-dependent diabetes mellitus in mice. The authors adapted this method using neonatal mice and determined the long-term effects of STZ injection in the mice. After receiving intraperitoneal injections of STZ at postnatal day 3 (P3), P4 and P8, male and female mice were hyperglycemic by week 4. A clear sex difference was found, with blood glucose levels in STZ-treated males remaining higher than those in STZ-treated females until week 23. Whereas STZ-treated males remained hyperglycemic until week 23, STZ-treated females did not have significantly higher glucose levels than control mice after week 18. Additionally, STZ-treated mice had neoplastic lesions in their livers by week 4, with a progression in the severity of these lesions until week 24. The results confirm that, in addition to pancreatic beta cell toxicity, STZ has an oncogenic effect on the liver when administered to neonates.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Body weights of male (a) and female (b) STZ-treated and control mice between week 4 and week 23.
Figure 2: Blood glucose concentrations of male (a) and female (b) STZ-treated and control mice between week 4 and week 23.
Figure 3
Figure 4: Non-neoplastic hepatic lesions present in STZ-treated mice.
Figure 5: Neoplastic hepatic lesions present in STZ-treated mice at week 24.

Similar content being viewed by others

References

  1. Bolzán, A.D. & Bianchi, M.S. Genotoxicity of streptozotocin. Mutat. Res. 512, 121–134 (2002).

    Article  Google Scholar 

  2. Rakieten, N., Rakieten, M.L. & Nadkarni, M.V. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29, 91–98 (1963).

    PubMed  Google Scholar 

  3. Schnedl, W.J., Ferber, S., Johnson, J.H. & Newgard, C.B. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326–1333 (1994).

    Article  CAS  Google Scholar 

  4. Deeds, M.C. et al. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 45, 131–140 (2011).

    Article  CAS  Google Scholar 

  5. Saini, K.S., Thompson, C., Winterford, C.M., Walker, N.I. & Cameron, D.P. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic β-cell line, INS-1. Biochem. Mol. Biol. Int. 39, 1229–1236 (1996).

    CAS  PubMed  Google Scholar 

  6. Rossini, A.A., Appel, M.C., Williams, R.M. & Like, A.A. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 26, 916–920 (1977).

    Article  CAS  Google Scholar 

  7. Like, A.A. & Rossini, A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417 (1976).

    Article  CAS  Google Scholar 

  8. Ito, M., Kondo, Y., Nakatani, A. & Naruse, A. New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin. Biol. Pharm. Bull. 22, 988–989 (1999).

    Article  CAS  Google Scholar 

  9. Pelegrin, M. et al. Evidence from transgenic mice that interferon-β may be involved in the onset of diabetes mellitus. J. Biol. Chem. 273, 12332–12340 (1998).

    Article  CAS  Google Scholar 

  10. Otaegui, P.J. et al. Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia. Hum. Gene Ther. 11, 1543–1552 (2000).

    Article  CAS  Google Scholar 

  11. Mas, A. et al. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle. Diabetes 55, 1546–1553 (2006).

    Article  CAS  Google Scholar 

  12. Cunha, A.R., Aguila, M.B. & Mandarim-de-Lacerda, C.A. Effects of early postnatal hyperglycaemia on renal cortex maturity, endothelial nitric oxide synthase expression and nephron deficit in mice. Int. J. Exp. Pathol. 89, 284–291 (2008).

    Article  Google Scholar 

  13. Ariza, L. et al. Inducción de diabetes experimental por administracción de estreptozotocina a ratones neonatos [Spanish]. Proceedings of the XI National Congress of the Spanish Society for Laboratory Animal Science, Valencia, Spain, 22–25 November 2011.

  14. Kataoka, M. et al. Recovery from diabetes in neonatal mice after a low-dose streptozotocin treatment. Biochem. Biophys. Res. Commun. 430, 1103–1108 (2013).

    Article  CAS  Google Scholar 

  15. Hartmann, K., Besch, W. & Zühlke, H. Spontaneous recovery of streptozotocin diabetes in mice. Exp. Clin. Endocrinol. 93, 225–230 (1989).

    Article  CAS  Google Scholar 

  16. Le May, C. et al. Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. USA 103, 9232–9237 (2006).

    Article  CAS  Google Scholar 

  17. Ernst, S., Demirci, C., Valle, S., Velasquez-Garcia, S. & Garcia-Ocaña, A. Mechanisms in the adaptation of maternal β-cells during pregnancy. Diabetes Manag. (Lond.) 1, 239–248 (2011).

    Article  CAS  Google Scholar 

  18. Toth, B. A critical review of experiments in chemical carcinogenesis using newborn animals. Cancer Res. 28, 727–738 (1968).

    CAS  PubMed  Google Scholar 

  19. Arison, R.N. & Feudale, E.L. Induction of renal tumour by streptozotocin in rats. Nature 214, 1254–1255 (1967).

    Article  CAS  Google Scholar 

  20. Rakieten, N., Gordon, B.S., Cooney, D.A., Davis, R.D. & Schein, P.S. Renal tumorigenic action of streptozotocin (NSC-85998) in rats. Cancer Chemother. Rep. 52, 563–567 (1968).

    CAS  PubMed  Google Scholar 

  21. Rakieten, N. et al. Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proc. Soc. Exp. Biol. Med. 137, 280–283 (1971).

    Article  CAS  Google Scholar 

  22. Rakieten, N. et al. Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes. Proc. Soc. Exp. Biol. Med. 151, 356–361 (1976).

    Article  CAS  Google Scholar 

  23. Iwase, M., Nunoi, K., Sadoshima, S., Kikuchi, M. & Fujishima, M. Liver, kidney and islet cell tumors in spontaneously hypertensive and normotensive rats treated neonatally with streptozotocin. Tohoku J. Exp. Med. 159, 83–90 (1989).

    Article  CAS  Google Scholar 

  24. Sibay, T.M. & Hayes, J.A. Potential carcinogenic effect of streptozotocin. Lancet 2, 912 (1969).

    Article  CAS  Google Scholar 

  25. Weisburger, J.H. et al. The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy. Recent Results Cancer Res. 52, 1–17 (1975).

    Article  CAS  Google Scholar 

  26. Berman, L.D., Hayes, J.A. & Sibay, T.M. Effect of streptozotocin in the Chinese hamster (Cricetulus griseus). J. Natl. Cancer Inst. 51, 1287–1294 (1973).

    Article  CAS  Google Scholar 

  27. Hard, G.C. Identification of a high-frequency model for renal carcinoma by the induction of renal tumors in the mouse with a single dose of streptozotocin. Cancer Res. 45, 703–708 (1985).

    CAS  PubMed  Google Scholar 

  28. Gruys, M.E. et al. Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype. Cancer Res. 61, 6255–6263 (2001).

    CAS  PubMed  Google Scholar 

  29. Beppu, T. et al. High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice. J. Thromb. Haemost. 8, 2514–2522 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de Biotecnologia Animal i Teràpia Gènica (CBATEG), Universitat Autònoma de Barcelona, Barcelona, Spain

    Lorena Ariza, Mireia Zaguirre, Marta García,  Ester Blasco,  Rosa Maria Rabanal,  Assumpició Bosch & Pedro José Otaegui

  2. Harlan Laboratories, Barcelona, Spain

    Marta García

  3. Departament de Medicina i Cirurgia Animals, Universitat Autònoma de Barcelona, Barcelona, Spain

    Ester Blasco &  Rosa Maria Rabanal

Authors
  1. Lorena Ariza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mireia Zaguirre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marta García
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ester Blasco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rosa Maria Rabanal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Assumpició Bosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pedro José Otaegui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro José Otaegui.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ariza, L., Zaguirre, M., García, M. et al. Hyperglycemia and hepatic tumors in ICR mice neonatally injected with streptozotocin. Lab Anim 43, 242–249 (2014). https://doi.org/10.1038/laban.530

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/laban.530

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing